Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Ectoin helps prevent cortisone-induced skin problems and supports skin health.

Dental pulp stem cells are better for tissue repair, while fat tissue stem cells may be more suited for wound healing and hair growth.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Most dogs with adrenal-dependent hypercortisolism had normal blood pressure after one year of treatment or surgery.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Anabolic steroid users may face higher risk of severe COVID-19.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Celiac disease requires more than just a gluten-free diet for effective management.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Lifestyle changes and environmental strategies can help address declining testosterone levels.

Intralesional pentoxifylline effectively and safely treats alopecia areata, improving hair regrowth.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

New compounds may help treat heart disease by activating specific potassium channels.

Low-dose oral minoxidil effectively treats alopecia but can cause side effects like excess hair growth and fluid retention.

Androgenic alopecia is linked to more severe COVID-19 and higher mortality.

Myhre syndrome symptoms worsen over time, with specific genetic variants affecting severity.

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Fenugreek extract may help treat benign prostatic hyperplasia.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Primary and secondary hair follicle cells in Cashmere goats have different gene expressions affecting hair growth and size.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.